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Abstract
Mass spectrometry imaging (MSI) is an analytical technique for the unlabeled and multiplex imaging of molecules in biological
tissue sections. It therefore enables the spatial and molecular annotations of tissues complementary to histology. It has already
been shown thatMSI can guide subsequent material isolation technologies such as laser microdissection (LMD) to enable a more
in-depth molecular characterization of MSI-highlighted tissue regions. However, with MSI now reaching spatial resolutions at
the single-cell scale, there is a need for a precise co-registration between MSI and the LMD. As proof-of-principle, MSI of lipids
was performed on a breast cancer tissue followed by a segmentation of the data to detect molecularly distinct segments within its
tumor areas. After image processing of the segmentation results, the coordinates of theMSI-detected segments were passed to the
LMD system by three co-registration steps. The errors of each co-registration step were quantified and the total error was
found to be less than 13 μm. With this link established, MSI data can now accurately guide LMD to excise MSI-
defined regions of interest for subsequent extract-based analyses. In our example, the excised tissue material was
then subjected to ultrasensitive microproteomics in order to determine predominant molecular mechanisms in each of
the MSI-highlighted intratumor segments. This work shows how the strengths of MSI, histology, and extract-based
omics can be combined to enable a more comprehensive molecular characterization of in situ biological processes.
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Introduction
Mass spectrometry imaging (MSI) is a powerful tool for the
non-labeled and parallel imaging of hundreds to thousands of
molecules in a single biological tissue section. It allows
obtaining cell type–specific molecular patterns and conversely
the annotation of tissues based on their molecular profiles [1].
The latter capability has, for instance, been used for the chem-
ical and spatial descriptions of tumors to reveal molecularly
distinct tumor cell populations [2].
Image co-registration has already performed in MSI. This
has enabled researchers increasing the MSI resolution mathe-
matically to fuse 3D MSI data to the MRI space, to align
multiple MSI datasets from a single sample, or to guide MSI
experiments based on the tissue’s morphology [3–6].
Likewise, few studies have already used MSI to guide
laser microdissection (LMD) systems to isolate regions
of interest (ROIs) from the target tissue, but no infor-
mation on the accuracy of spatial co-registration has
been evaluated or reported [7, 8]. Since MSI now rou-
tinely reaches a spatial resolution of 10 μm on commer-
cial systems, the co-registration accuracy becomes cru-
cial in order to retain the detailed spatial information
provided by MSI in the LMD system.
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Here we present an accurate co-registration (considering
the currently achievable spatial resolution) of MSI to LMD
on the same tissue section and after hematoxylin and eosin
staining. We will show how this system can be used to
comprehensively and accurately characterize tumor




Residual (fresh) breast cancer tissue was collected by the
Tissue Biobank of the University of Liege, directly frozen in
liquid nitrogen, and then stored at − 80 °C. The standardized
protocol was approved by the Ethics Committee of the
University Hospital Center of Liege. Informed consent was
obtained from the participant included in this study. A cryo-
section of 12-μm thickness was thaw-mounted on a polyeth-
ylene naphthalate (PEN) membrane sl ide (Leica
Microsystems, Wetzlar, Germany) and stored at − 80 °C until
analysis.
Mass spectrometry imaging
All solvents, if not stated otherwise, were purchased from
Biosolve (Dieuze, France). First, the membrane slide
was desiccated for 30 min at room temperature. Several fidu-
cial markers were applied next to the tissue using water-based
Tipp-Ex (BIC, Paris, France) for later co-registration purposes.
Five milligrams per milliliter α-cyano-4-hydroxycinnamic ac-
id (Sigma Aldrich, St. Louis, MO, USA) in 70% acetonitrile
and 0.2% trifluoroacetic acid was sprayed in eight layers using
an HTX-TM sprayer (Chapel Hill, NC, USA) onto the tissue
section with a constant flow rate of 0.1 ml/min and at a speed
of 1300mm/min. The breast cancer section wasmeasuredwith
a MALDI HDMS SYNAPT G2-Si (Waters, Manchester, UK)
which is compatible with non-conductive PEN membrane
slides. The experiment was performed in positive mode and
at 70-μm spatial resolution within a mass range of m/z 350–
1600 in which mostly lipids are detected. Red phosphorus was
used for external calibration.
Staining and optical images
Directly after the MSI experiment, a digital high-resolution
image of the slide with matrix was obtained with a microscop-
ic slide scanner (Mirax Desk, Zeiss, Jena, Germany), subse-
quently referred to as the optical image.
Then, the matrix was removed with 70% ethanol and
stained for hematoxylin and eosin (H&E) used as standard
protocol (Milli-Q water 3 min, hematoxylin 90 s, tap water
3 min, eosin 30 s, tap water 3 min, 100% ethanol 1 min,
xylene 30 s). The H&E-stained tissue section was not covered
with a cover slip but immediately scanned with the same mi-
croscopic slide scanner and stored at − 80 °C until LMD. This
resulted in a digital optical image, subsequently referred to as
the H&E image.
Both digital high-resolution images were downscaled
1:4 for better handling using the scan viewer software
(Pannoramic Viewer, 3DHISTECH Ltd., Budapest,
Hungary) which resulted in a pixel size of 2.076 μm
for x and 2.084 μm for y (12,235 × 12,189 dpi).
Co-registration, data analysis, and image processing
These images were imported together with the MSI data into
MATLAB R2017b (MathWorks, Natick, MA, USA) for co-
registration of the images (MSI, optical and H&E; Fig. 1), data
analysis, and image processing with the Image Processing
toolbox (v.10.1). All image co-registrations were performed
using affine geometric transformation (command fitgeotrans).
Every spectrum of theMSI data was normalized to its total ion
current. Tumor-associated spectra were clustered using non-
negative matrix factorization (NNMF) where each pixel is
assigned to the component with the highest score. After
image processing of the segmentation results (see
Electronic Supplementary Material (ESM), Figs. S3
and S4), the coordinates of the regions belonging to
the segments were recalculated with respect to the co-
ordinates of the fiducial markers in the optical image
and written into an XML file for compatibility with
subsequent LMD system.
Laser microdissection
Laser microdissection was performed using a Leica LMD
7000 (Leica Microsystems, Wetzlar, Germany). This system
supports the import of external coordinate information of
areas to be cut out in form of an XML file. Areas were dis-
sected from the H&E-stained tissue sections with the follow-
ing settings: wavelength 349 nm, power 20, aperture 45, speed
15, specimen balance 0, head current 100%, and pulse fre-
quency 501 Hz. The microdissected regions were collected
in 0.5-ml centrifuge tubes and stored at − 80 °C until further
analysis.
Microproteomics analysis
For every MSI segment, a total of 0.3-mm2 dissected material
was prepared and analyzed by an optimized LC-MS/MS pro-
tocol for bottom-up proteomics of very small samples (~ 2000
cells) using an ultraperformance liquid chromatography
(UPLC) 2D nanoACQUITY (Waters, Corp., Milford, USA).
This was done as described previously [9], but without
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paraffin removal and antigen retrieval due to the use of fresh-
frozen tissue sections.
Protein identification and label-free quantification (LFQ)
were performed using MaxQuant v.1.5.6.5 with the following
settings: UniProt reviewed human database, trypsin digestion
with maximum two missed cleavage sites, methionine oxida-
tion as variable modification and carbamidomethyl cysteine as
fixed modification, a minimal peptide length of seven amino
acids, at least two peptides per protein (of which at least one is
unique), and a maximum false discovery rate of 1%. The
label-free intensities were normalized using the MaxLFQ al-
gorithm [10].
Data analysis was performed with Perseus v.1.6.2.2
[11]. Proteins identified as “reverse”, “only identified
by site”, or “potential contaminants” hits were removed.
The LFQ intensities were log2-transformed and z-scored
before performing a hierarchical clustering of the pro-
teins with the following settings: Euclidean distance,
complete linkage, based on a preprocessing with k-
means with 300 clusters, 10 iterations, and 1 restart.
Under- and overexpressed proteins were selected based
on z-scores being exclusively ≤ − 1 or ≥ + 1, respective-
ly. The gene IDs corresponding to the under- and
overexpressed proteins were then imported into the
PANTHER v.13.1 gene ontology classification system
[12].
Results and discussion
The aim of this study is to create a pipeline where MSI data is
used to accurately guide the LMD system for further analysis
on the very same tissue section with potential applications in
biomedical research. This pipeline consists in several steps
which are listed in ESM, Protocol S1.
MSI of breast cancer tissue
MSI of lipids was performed on a fresh-frozen breast cancer
tissue section, which was mounted onto an LMD-compatible
membrane slide to be able to use the same section for MSI and
LMD. We used a high-pressure MALDI mass spectrometer,
which leaves most of the membrane unaffected and therefore
usable by an LMD system. Three co-registration steps had to
be performed to couple the obtained MSI data to the LMD
system (Fig. 1).
Co-registration of MSI and LMD
The first step consisted of co-registering the MSI data to the
high-resolution optical image of the tissue with matrix (Fig.
1(I)). To bemost accurate and overcome limitations in vendor-
shipped software, this was achieved by directly matching the
coordinates of three manually selected MSI pixels with their
Fig. 1 Co-registration steps from mass spectrometry imaging (MSI) to
laser microdissection (LMD). Several co-registration steps are needed in
order to transfer spatial information fromMSI to the LMD system (orange
arrows). First, the MSI data was co-registered to the high-resolution op-
tical image of the tissue section via the visible laser shots in the matrix
(ESM, Fig. S1) directly after the MSI experiment (I). The optical image
was then further matched to its high-resolution H&E image via fiducial
markers (II). Finally, coordinates in the H&E image were recalculated
using fiducial markers that are both visible in the H&E image and in
the LMD live image (III). The established link between MSI, histology,
and LMD allows transferring region-of-interest information from MSI,
for instance spatial segments identified by a multivariate clustering of the
spectra, to the LMD system (blue-dashed arrows)
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corresponding visible laser-shot landmarks in the optical im-
age (ESM, Fig. S1a). An affine geometric transformation was
derived from these points and used to transform all MSI pixels
into the coordinate system of the optical image (and vice
versa). The co-registration error was estimated by counting
the number of pixels in the optical image (~ 2 μm) from the
center of the laser shot landmark to the corresponding MSI
pixel (ESM, Fig. S1b). The error was on average 7.9 μm in x
and 4 μm in y (Table 1).
The second co-registration needed is between the optical
and the H&E images in order to incorporate the histological
information into the data analysis (Fig. 1(II)). The manual
selection of three control point pairs was based on the same
features of the fiducial markers in both optical images, which
enabled the creation of an affine geometric transformation.
Themanual selection of co-registration points induces an error
which was estimated by performing five manual co-
registrations of the optical image with itself and calculating
the average of the Euclidean distances between all original
and transformed positions. The average error was 1.4 μm for
both x and y (Table 1).
The fiducial markers were also used to translate coordi-
nates from the optical image to the coordinate system of the
LMD (Fig. 1(III)). Three landmark points were manually se-
lected in the optical image for this purpose. One of these is
used as origin point, which means that all other coordinates
belonging to the two remaining landmarks and the regions of
interest (ROIs) are recalculated with respect to that reference
point. These new coordinates were then written into an XML
file to import the ROIs into the LMD software. During the
import process, the exact same teaching points, previously
defined in the optical image, had to be selected in the LMD
live image of the slide. The error of this co-registration step
was estimated by comparing expected and observed distances
between cut co-registered shapes and micrometer-sized
Tipp-Ex spots (~ 3 μm) in the LMD live image (ESM,
Fig. S2). The average error was 3.5 μm in x and
7.4 μm in y (Table 1). The error was evaluated at × 5
magnification which corresponds to the lowest magnifi-
cation level of the LMD. While this magnification en-
ables a large field of view, which was necessary for the co-
registration, it also provides the lowest detail level for
matching the previously selected landmarks in the optical im-
age to their representations in the LMD live image.
It is important to mention that in all co-registration steps,
the teaching points were selected manually which influence
the alignment quality of both co-registered objects. Moreover,
the estimation of the reported errors in the optical images was
based on visual evaluation which also introduces bias and
error. We addressed this issue by repeating each co-
registration at least three times (Table 1).
In summary, the co-registration error for each step was
below 10 μm. We note that these errors could be reduced by
using a higher magnification in the LMD (ESM, Table S1) or a
higher resolution of the optical images (ESM, Table S2). We
also want to point out that the reported errors are control point
based and do not account for additional errors due to morpho-
logical deformations during histological staining. We expect
that powerful elastic image registration using the tissue’s own
features, which must therefore be clearly visible in highly
resolvedMSI images, could decrease these detrimental effects
[13]. Although it is not possible to evaluate if the errors in the
three steps are additive or subtractive, we expect the co-
registration error to be below 13 μm in both dimensions, con-
sidering additive error components (Table 1).
Detection of molecular distinct tumor populations
by MSI
In this study, the usefulness and feasibility of the established
MSI-LMD link are demonstrated by the investigation of
intratumor heterogeneity in a breast cancer sample.
In order to investigate intratumor heterogeneity, a patholo-
gist first delineated the tumor areas in the H&E-stained tissue
section (Fig. 2(a)). For high accuracy, these annotations were
done on the high-resolution image in the scan viewer soft-
ware. The annotations and theH&E image were then imported
into MATLAB and co-registered to the MSI data. This allows
exclusive selection of tumor-specific MSI data.
As previously demonstrated, unsupervised multivariate
analysis can be used to reveal intratumor heterogeneity
through MSI-based tissue segmentation [2]. Here, the tumor
areas were partitioned applying the NNMF algorithm to the
MSI data. The average Silhouette coefficient was maximized
in order to determine the optimal number of segments. In a
range from two to five, the optimal number of segments was
found to be three (ESM, Table S3).
Table 1 Co-registration errors




Error in x (μm) 7.89 ± 4.06 SD 1.39 ± 0.33 SD 3.46 ± 2.62 SD 12.74 ± 4.84 SD
Error in y (μm) 3.96 ± 4.32 SD 1.39 ± 0.50 SD 7.39 ± 3.78 SD 12.74 ± 5.76 SD
MSI, mass spectrometry imaging; LMD, laser microdissection; H&E, hematoxylin and eosin; SD, standard deviation
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Image processing was performed on the segmentation re-
sults in order to increase the practicability of microdissection.
This included at first a smoothing of the segmentation image
using the imopen MATLAB function with a 2 × 2 square as
structuring element (ESM, Fig. S3). The segmentation image
was then divided into three binary images, each depicting the
pixels belonging to one of the segments, and which were
further processed individually (ESM, Fig. S4). This included
the removal of impurities within the binary image by deleting
small areas (≤ 30 pixels in the 4-connected neighborhood)
using bwareaopen and filling holes in the 8-connected neigh-
borhood using imfill (ESM, Fig. S4). The individual binary
images were then warped to the dimensions of the histological
image using imwarp with nearest-pixel interpolation
(Fig. 2(b)). Once upscaled, the last step of the image
processing was to detect the external boundaries of all
Fig. 2 Laser microdissection of
MSI-defined intratumor segments
subsequently characterized by
microproteomics. (a) First, tumor
areas were annotated by a pathol-
ogist on the H&E image. (b)
Then, mass spectrometry imaging
(MSI) lipid data of the tumor was
used to spatially segment the tu-
mor areas into three clusters using
non-negative matrix factorization.
After image processing of the
segments including smoothing
and boundary detection (ESM,
Figs. S3 and S4), the segmenta-
tion image was upscaled to the
resolution of the H&E image. (c)
The segments’ boundaries were
finally transferred to the LMD
software using the previously
established co-registration pipe-
line. Each MSI cluster was then
microdissected by the LMD sys-
tem for the subsequent
microproteomics analysis. This
resulted in the identification and
label-free quantification of over
1000 common proteins. Cluster
exclusive over- and under-
expressed proteins were submit-
ted to gene ontology analysis
(ESM, Fig. S5). (d) shows select-
ed differences in molecular func-
tions between the clusters (in
percentage points with respect to
cluster 2)
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regions belonging to a segment using bwboundaries
(ESM, Fig. S4). Finally, the boundary coordinates of each
MSI segment were recalculated with respect to the selected
origin point present in the optical image and were used to
generate the XML file in the LMD-compatible format.
Laser microdissection and microproteomics
characterization of MSI segments
The ROIs were available and visible in the field of view
of the LMD software after import of the MSI-based ROI
information into the LMD system (Fig. 2(c)). These ROIs
were then microdissected (Fig. 2(c)) and collected into
tubes for a further molecular characterization of the dif-
ferent tumor cell populations represented by the MSI seg-
ments using quantitative 2D-LC-MS/MS microproteomics.
A total of 1426 common proteins were identified among
theMSI segments (ESM, Table S4). After LFQ normalization,
log2-transformation, and standardization, 1040 proteins
remained to characterize the molecular properties of the dif-
ferent tumor subpopulations (ESM, Table S5). As expected
when analyzing samples from the same tissue section, few
proteins (on average 25.3) were found exclusively up- or
downregulated in each MSI segment when using a z-
score threshold of + 1 and − 1, respectively (ESM, Fig.
S5a). The subsequent functional annotation based on
those proteins showed that the three MSI segments
mainly differed from each other in processes related to
metabolic processes, biological adhesion, immune sys-
tem process, response to stimulus, and locomotion
(Fig. 2(d) and ESM, Fig. S5b). The observation of func-
tional differences between the different tumor regions
confirms the presence of molecular and functional
intratumor heterogeneity in this breast cancer sample.
Conclusion
Mass spectrometry imaging (MSI) continues its development
toward a higher spatial resolution and cellular sensitivity but
still lacks chromatographic separation to mitigate ion suppres-
sion. A transfer of spatial MSI information to a laser micro-
dissection (LMD) system for the targeted isolation of cellular
material followed by bottom-up proteomics must be corre-
spondingly accurate. As MSI systems nowadays achieve res-
olutions around 10 μm, co-registration errors should ideally
not be larger than a few MSI pixels. Here we achieved an
accurate coupling of MSI to LMD with co-registration errors
on a single MSI pixel level, namely below 13 μm.While here
we focused on microproteomics experiments, the excised
samples could be analyzed by any other omics technology
compatible with MSI. Our approach ultimately brings togeth-
er spatial and molecular information for a better understanding
of in situ molecular mechanisms in complex tissues.
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